{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:41:39Z","timestamp":1787740899591,"version":"build-2784847793"},"reference-count":19,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,13]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>FAS can be mutated in individuals diagnosed with unicentric and idiopathic multicentric Castleman disease. Defective lymphocyte apoptosis may be a pathological mechanism shared between Castleman disease and autoimmune lymphoproliferative syndrome.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018023911","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T11:49:16Z","timestamp":1541591356000},"page":"2959-2963","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":17,"title":["A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease"],"prefix":"10.1182","volume":"2","author":[{"given":"Turner S.","family":"Baker","sequence":"first","affiliation":[{"name":"Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyne J.","family":"Gambino","sequence":"additional","affiliation":[{"name":"Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Schriefer","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Yeon","family":"Lim","sequence":"additional","affiliation":[{"name":"Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn Meltz","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, and"},{"name":"McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7367-8184","authenticated-orcid":false,"given":"David C.","family":"Fajgenbaum","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00edn Garc\u00eda-Sancho","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario de Salamanca and Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Centro de Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer, Salamanca, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2830-4079","authenticated-orcid":false,"given":"Minji","family":"Byun","sequence":"additional","affiliation":[{"name":"Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY;"},{"name":"Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"issue":"19","key":"2020021108394876800_B1","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2013-12-545087","article-title":"HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy","volume":"123","author":"Fajgenbaum","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2020021108394876800_B2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ajh.23291","article-title":"The clinical spectrum of Castleman\u2019s disease","volume":"87","author":"Dispenzieri","year":"2012","journal-title":"Am J Hematol"},{"issue":"4","key":"2020021108394876800_B3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5045\/br.2014.49.4.253","article-title":"Clinical features and outcomes in patients with human immunodeficiency virus-negative, multicentric Castleman\u2019s disease: a single medical center experience","volume":"49","author":"Seo","year":"2014","journal-title":"Blood Res"},{"issue":"1","key":"2020021108394876800_B4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cas.13439","article-title":"Clinical characteristics and outcomes of Castleman disease: a multicenter study of 185 Chinese patients","volume":"109","author":"Zhang","year":"2018","journal-title":"Cancer Sci"},{"issue":"12","key":"2020021108394876800_B5","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2020021108394876800_B6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ajh.20283","article-title":"Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena","volume":"78","author":"Ocio","year":"2005","journal-title":"Am J Hematol"},{"issue":"3","key":"2020021108394876800_B7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ajhg.2016.07.005","article-title":"A whole-genome analysis framework for effective identification of pathogenic regulatory variants in Mendelian disease","volume":"99","author":"Smedley","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"6805","key":"2020021108394876800_B8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","article-title":"CD95's deadly mission in the immune system","volume":"407","author":"Krammer","year":"2000","journal-title":"Nature"},{"issue":"6","key":"2020021108394876800_B9","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"issue":"5215","key":"2020021108394876800_B10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"issue":"14","key":"2020021108394876800_B11","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2020021108394876800_B12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/gim.0b013e3182310b7d","article-title":"Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance","volume":"14","author":"Hsu","year":"2012","journal-title":"Genet Med"},{"issue":"10","key":"2020021108394876800_B13","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.4049\/jimmunol.1100021","article-title":"FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome","volume":"186","author":"Kuehn","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"2020021108394876800_B14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI43752","article-title":"Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation","volume":"121","author":"Magerus-Chatinet","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"2020021108394876800_B15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.alit.2014.08.009","article-title":"Multicentric Castleman\u2019s disease with impaired lymphocytic apoptosis","volume":"64","author":"Minemura","year":"2015","journal-title":"Allergol Int"},{"issue":"1","key":"2020021108394876800_B16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1163\/15685590051129832","article-title":"Lymphoma in Castleman\u2019s disease, acute lymphocytic leukemia, adult T-cell leukemia and cutaneous T-cell lymphoma accompanied with high serum soluble Fas ligand levels","volume":"30","author":"Takubo","year":"2000","journal-title":"Haematologia (Budap)"},{"issue":"1","key":"2020021108394876800_B17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.07595.x","article-title":"Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome","volume":"145","author":"Teachey","year":"2009","journal-title":"Br J Haematol"},{"issue":"suppl 1","key":"2020021108394876800_B18","first-page":"3593","article-title":"Prolonged remission achieved in a relapsing idiopathic multicentric Castleman disease patient with a novel, targeted treatment approach","volume":"130","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2020021108394876800_B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOP.0b013e32834ea739","article-title":"New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome","volume":"24","author":"Teachey","year":"2012","journal-title":"Curr Opin Pediatr"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/21\/2959\/1629839\/advances023911.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/21\/2959\/1629839\/advances023911.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T09:14:36Z","timestamp":1581412476000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/21\/2959\/16199\/A-novel-FAS-mutation-with-variable-expressivity-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":19,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2018,11,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018023911","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,7]]}}}